Publications Update # 106
MAPK/FAK Clamp - RAMP 201 Avutomentinib and Defactinib in Low Grade Ovarian, IP chemotherapy question, ROSELLA Trial and PROFECTA-II Trial, Palliative Oophorectomy in gastric cancers
Publications Update
Publications Update # 105
Making magic with Brad Meltzer, venous thromboembolism during ambulatory chemotherapy in endometrial cancer (including the NCCN and ASCO guidelines), IMRT in vulvar cancer, and hypofractionated adjuvant radiation in cervical cancer patients.
Publications Update # 104
New Episode of GYOEDU Podcast, ASCO abstracts - Challenge trial, TRUST trial, cytoxan+Avastin vs. cytoxan+Avastin+Pembrolizumab, Menopause management with Elinzatenant, and a review of cancer of unknown primary site.
Publications Update # 103
MIS in cervical cancer in SHAPE trial-eligible patients, pragmatic testing with IHC rather to replace the PROMISE algorithm and two questions about PFT and vulvar cancer groin management.
Publications Update # 102
Happiest country, PDS Vs. NACT a fresh perspective (video), fear in the OR, and a vulvar cancer review article worth reading.
Publications Update # 101
Interview with Isabel Allende, updated tips for staying organized for the board prep, p53 staining in endometrial cancer, secondary debulking in platinum-sensitive ovarian cancer, Epigenetic MLH1 and outcomes
Publications Update # 100
Unreasonable hospitality, mini-tutorial juvenile granulosa cell tumor, when to make a protective stoma in ovarian cancer, NRG-GY023 trial, finding the ureter and RSO surgical technique and a review paper on HGSOC
Publications Update # 99
Managing perfectionism, conization prior to open radical hysterectomy, KELIM score in ovarian cancer with mini-video tutorial
Publications Update # 98
"Have you been there?" an award winning speech, INSPIRE-4 clinical trial discussing intra-abdominal infection treatment, Phase 2 LIGHT study exploring PARPs in ovarian cancer, link to a prior PARP tutorial, consolidation cycles in GTN treatment
Publications Update # 97
Taylor Swift and her business, venous thromboembolism in cancer patients - duration of treatment, dose of pembrolizumab and lenvatinib, metformin in endometrial cancer, and the cost of ADCs